Cancer chemotherapy impairs contextual but not cue-specific fear memory

Behavioural Brain Research

Volumn 181, Issue 1, 2007, Pages 168-172

  MacLeod, Jill E ^a   DeLeo, Joyce A ^b   Hickey, William F ^b   Ahles, Tim A ^b   Saykin, Andrew J ^b   Bucci, David J ^a  

^a Dartmouth College   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Cyclophosphamide; Doxorubicin; Learning; Rat

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CONDITIONING; CONTROLLED STUDY; FEAR; FEMALE; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; MEMORY; MEMORY DISORDER; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; CUES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEAR; FEMALE; FREEZING REACTION, CATALEPTIC; MEMORY; MEMORY DISORDERS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34248581978     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.04.003     Document Type: Article

References (35)

1. Anagnostaras S.G., Gale G.D., and Fanselow M.S. Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11 (2001) 8-17
2. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., et al. Neuropsychological impact of standard-dose chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20 (2002) 485-493
3. Arenos J.D., Musty R.E., and Bucci D.J. Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur J Pharmacol 539 (2006) 177-183
4. Brezden C., Philips K., and Abdolell M. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18 (2000) 2695-2701
5. Brizzee K.R., Ordy J.M., Kaack M.B., and Beavers T. Effect of prenatal ionizing radiation on the visual cortex and hippocampus of newborn squirrel monkeys. J Neuropathol Exp Neurol 39 (1980) 523-540
6. Burwell R.D., Saddoris M.P., Bucci D.J., and Wiig K.A. Corticohippocampal contributions to spatial and contextual learning. J Neurosci 24 (2004) 3826-3836
7. Corcoran K.A., and Maren S. Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. J. Neurosci 21 (2001) 1720-1726
8. Crepel V., Epsztein J., and Ben-Ari Y. Ischemia induces short- and long-term remodeling of synaptic activity in the hippocampus. J Cell Mol Med 7 (2003) 401-407
9. Dietrich J., Han R., Yang Y., Mayer-Proschel M., and Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5 22 (2006) 1-23
10. Ferrell B., and Hassey-Dow K. Quality of life among long-term cancer survivors. Oncology 11 (1997) 565-576
11. Galea L.A., Kavaliers M., Ossenkopp K.P., and Hampson E. Gonadal hormone levels and spatial learning performance in the Morris water maze in male and female meadow voles, Microtus pennsylvanicus. Horm Behav 29 (1995) 106-125
12. Good M., and Honey R.C. Dissociable effects of selective lesions to hippocampal subsystems on exploratory behavior, contextual learning, and spatial learning. Behav Neurosci 111 (1997) 487-493
13. Holland P.C., and Bouton M.E. Hippocampus and context in classical conditioning. Curr Opin Neurobiol 9 (1999) 195-202
14. Jarrell J., Lai E.V., Barr R., McMahon A., Belbeck L., and O'Connell G. Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat. Cancer Res 47 (1987) 2340-2343
15. Jansen C., Miaskowski C., Dodd M., Dowling G., and Kramer J. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32 (2005) 1151-1163
16. Keime-Guibert F., Napolitano M., and Delattre J.Y. Neurological complications of radiotherapy and chemotherapy. J Neurol 245 (1998) 695-708
17. Knowlton B.J., and Fanselow M.S. The hippocampus, consolidation and on-line memory. Curr Opin Neurobiol 8 (1998) 293-296
18. Lee G.D., Longo D.L., Wang Y., Rifkind J.M., Abdul-Raman L., Mamczarz J.A., et al. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. Clin Cancer Res 12 (2006) 198-205
19. Maren S. Neurobiology of Pavlovian fear conditioning. Ann Rev Neurosci 24 (2001) 897-931
20. Maren S., Aharonov G., and Fanselow M.S. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 88 (1997) 261-274
21. McAllister T.W., Ahles T.A., Saykin A.J., Ferguson R.J., McDonald B.C., Lewis L.D., et al. Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments. Curr Psychiatry Rep 6 (2004) 364-371
22. Olin J.J. Cognitive function after systemic therapy for breast cancer. Oncology 15 (2001) 613-624
23. Phillips R., and LeDoux J. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn Memory 1 (1994) 34-45
24. Reiriz A.B., Reolon G.K., Preissler T., Rosado J.O., Henriques J.A., Roesler R., et al. Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 12 (2006) 5000
25. Saykin A.J., Ahles T.A., and McDonald B.C. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8 (2003) 201-216
26. Schagen S., Van Dam F., Muller M., Boogerd W., Lindeboom J., and Bruining P. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85 (1999) 640-650
27. Schmidt-Kastner R., and Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neurosci 40 (1991) 599-636
28. Stemmer S.M., Stears J.C., Burton B.S., Jones R.B., and Simon J.H. White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. AJNR Am J Neuroradiol 15 (1994) 1267-1273
29. Stoltenburg-Didinger G. Neuropathology of the hippocampus and its susceptibility to neurotoxic insult. Neurotoxicol 15 (1994) 445-450
30. Troy L., McFarland K., Littman-Power S., Kelly B.J., Walpole E.T., Wyld D., et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psycho-Oncology 9 (2000) 29-39
31. Tuxen M., and Hansen S. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 20 (1994) 191-214
32. van Dam F., Schagen S., and Muller M. Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: high dose versus standard dose chemotherapy. J Natl Cancer Inst 90 (1998) 210-218
33. Verstappen C.C., Heimans J.J., Hoekman K., and Postma T.J. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63 (2003) 1549-1563
34. Wick A., Wick W., Hirrlinger J., Gerhardt E., Dringen R., Dichgans J., et al. Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J Neurochem 91 (2004) 1067-1074
35. Winocur G., Vardy J., Binns M.A., Kerr L., and Tannock I. The effects of anti-cancer drugs, methotrexate and 5-fluorouracil on cognitive function in mice. Pharm Biochem Behav 85 (2006) 66-75